Literature DB >> 7682978

Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg.

Y Y Zhang1, B G Hansson, L S Kuo, A Widell, E Nordenfelt.   

Abstract

Sera from 410 patients from the Wuhan area in the central part of China with the diagnosis of chronic liver disease were analyzed for markers of hepatitis B, C and D virus infections. All sera, plus liver biopsy specimens from 188 of the patients, were also tested for hepatitis B virus DNA by polymerase chain reaction. Sixty-eight percent were HBsAg positive in serum, whereas 29% showed markers of past hepatitis B virus infection. Hepatitis B virus DNA was detected in all HBeAg-positive sera but also in 58% of patients with HBe antibody. In the liver specimens of the corresponding patient groups, 97% and 78%, respectively, were hepatitis B virus DNA positive. However, more noteworthy was that of the HBsAg-negative/HBs-antibody positive patients 30% had detectable hepatitis B virus DNA in serum and 32% had hepatitis B virus DNA in liver tissue, whereas in a control group of healthy blood donors, of which 90% had HBs antibody, none was hepatitis B virus DNA positive. Our results demonstrate that among patients with chronic liver disease, infections with hepatitis B virus or hepatitis B virus-related virus(es) may frequently occur without being revealed by conventional serological methods. Hepatitis C and D viruses seem to be of only minor importance in the pathogenesis of chronic liver disease in this part of China.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682978     DOI: 10.1002/hep.1840170403

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C.

Authors:  Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 2.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

3.  Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology.

Authors:  C Berasain; M Betés; A Panizo; J Ruiz; J I Herrero; M P Civeira; J Prieto
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

4.  Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China.

Authors:  Zhong-Liao Fang; Hui Zhuang; Xue-Yan Wang; Xian-Min Ge; Tim-J Harrison
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

5.  Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis.

Authors:  T Chiba; Y Matsuzaki; M Abei; J Shoda; T Aikawa; N Tanaka; T Osuga
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

6.  Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C.

Authors:  Hong Kim; Seoung-Ae Lee; Dong-Won Kim; Sueng-Hyun Lee; Bum-Joon Kim
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

7.  Occult hepatitis B virus infection in Lebanese patients with chronic hepatitis C liver disease.

Authors:  S Ramia; A I Sharara; M El-Zaatari; F Ramlawi; Z Mahfoud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03       Impact factor: 3.267

8.  Treatment of chronic replicative hepatitis B virus infection with short-term continuous infusion of foscarnet.

Authors:  R Schvarcz; B G Hansson; J O Lernestedt; O Weiland
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

9.  Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan.

Authors:  C-Y Dai; M-L Yu; S-C Chen; Z-Y Lin; M-Y Hsieh; L-Y Wang; J-F Tsai; W-L Chuang; W-Y Chang
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

10.  Past exposure to hepatitis B: a risk factor for increase in mortality?

Authors:  Raxitkumar Jinjuvadia; Suthat Liangpunsakul; Fadi Antaki
Journal:  J Clin Gastroenterol       Date:  2014-03       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.